![Michael Williams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Williams
Direttore/Membro del Consiglio presso
Sarcio, Inc.
Profilo
Michael Williams is currently a Board Member at Sarcio, Inc. and a Partner at PACE Healthcare Capital.
Previously, he served as a Non-Executive Director at PYC Therapeutics Ltd. in 2018 and as a Vice President at Bristol Myers Squibb Co. from 2004 to 2005.
He also held positions at Pfizer Inc. as a Vice President and at Intarcia Therapeutics, Inc. as a Chief Operating Officer.
Mr. Williams obtained his undergraduate degree from the University Of Bangor and his graduate degree in 1982 from the same institution.
Posizioni attive di Michael Williams
| Società | Posizione | Inizio |
|---|---|---|
PACE Healthcare Capital
 PACE Healthcare Capital Investment ManagersFinance PACE Healthcare invests in companies located in the United States. The firm focuses on digital healthcare and healthcare technology sectors. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.25 - 2 million. | Consulente / Consigliere | - |
Sarcio, Inc.
 Sarcio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing an off the shelf, injectable, regenerative therapy to delay or prevent the need for joint replacement | Direttore/Membro del Consiglio | 01/07/2021 |
Precedenti posizioni note di Michael Williams
| Società | Posizione | Fine |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Direttore/Membro del Consiglio | 11/04/2018 |
| BRISTOL-MYERS SQUIBB COMPANY | Investitore di Private Equity | 01/01/2005 |
| PFIZER INC. | Investitore di Private Equity | - |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Direttore operativo | - |
Formazione di Michael Williams
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
35
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
PYC Therapeutics Ltd.
 PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates | Health Technology |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
University Of Bangor
 University Of Bangor Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sarcio, Inc.
Sarcio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing an off the shelf, injectable, regenerative therapy to delay or prevent the need for joint replacement | Commercial Services |
PACE Healthcare Capital
PACE Healthcare Capital Investment ManagersFinance PACE Healthcare invests in companies located in the United States. The firm focuses on digital healthcare and healthcare technology sectors. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.25 - 2 million. | Finance |
